Kaihong Chen

ORCID: 0000-0001-9570-0509
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Metal-Organic Frameworks: Synthesis and Applications
  • Magnetism in coordination complexes
  • Molecular Sensors and Ion Detection
  • Chronic Kidney Disease and Diabetes
  • Extraction and Separation Processes
  • Phytochemical Studies and Bioactivities
  • Minerals Flotation and Separation Techniques
  • Cardiovascular Function and Risk Factors
  • Synthesis and pharmacology of benzodiazepine derivatives
  • Esophageal and GI Pathology
  • Medicinal Plant Pharmacodynamics Research
  • Lanthanide and Transition Metal Complexes
  • Porphyrin Metabolism and Disorders
  • Chemical Synthesis and Analysis
  • Estrogen and related hormone effects
  • Heart Failure Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Geomechanics and Mining Engineering
  • Birth, Development, and Health
  • Inflammatory Biomarkers in Disease Prognosis
  • Natural product bioactivities and synthesis
  • Folate and B Vitamins Research
  • Pancreatitis Pathology and Treatment

First Affiliated Hospital of Fujian Medical University
2016-2025

Fujian Medical University
2016-2025

Jiangxi Academy of Sciences
2008-2020

Second Affiliated Hospital of Shantou University Medical College
2016-2019

Shantou University
2016-2019

Guangdong Academy of Medical Sciences
2017

Guangdong General Hospital
2017

Southern Medical University
2017

Fuzhou University
2008

Wuxi People's Hospital
2006

A anionic zinc(II) metal–organic framework (MOF) {[(CH3)2NH2][Zn(FDA)(BTZ)2]}n (1) (H2FDA = furan-2,5-dicarboxylic acid and HBTZ 1H-benzotriazole) was synthesized under solvothermal conditions. This MOF demonstrates a rare planar 4-connected usf topology exhibits high thermal chemical stabilities. Postsynthetic cation exchange of 1 with Cu2+, Co2+, Ni2+ afforded series mixed-metal loaded MOFs: {[(CH3)2NH2][ZnxM1-x(FDA)(BTZ)2]}n (M2+@1) (M2+ x 0.59; M2+ 0.83; Ni2+, 0.58). More importantly, is...

10.1021/acs.cgd.8b00344 article EN Crystal Growth & Design 2018-05-29

BACKGROUND: Obesity is a factor contributing to the occurrence of hypertension and risk for adverse outcomes in populations with hypertension. The changes prevalence obesity remain unclear. Investigating can provide information treatment management METHODS: clinical data from adults aged ≥20 years were extracted National Health Nutrition Examination Survey 2001 2023. primary outcome was (body mass index≥30 kg/m 2 ). trend among American evaluated via test. RESULTS: age-standardized America...

10.1161/hypertensionaha.124.24123 article EN Hypertension 2025-01-06

The benefits of ideal cardiovascular-health metrics (ICVHMs) in patients with renal insufficiency remain unclear. This study aimed to investigate ICVHM associations prognosis a population. trial enrolled 29,682 participants from the US National Health and Nutrition Examination Survey (NHANES), 2007-2018, mortality follow-up through December 31, 2019. Participants were divided into three groups based on estimated glomerular filtration rates. Cardiovascular health was assessed using new...

10.1097/cm9.0000000000003461 article EN cc-by-nc-nd Chinese Medical Journal 2025-02-26

Abstract Background High blood pressure (BP) is a major risk factor for cardiovascular disease (CVD) events. The ideal health metrics (ICVHMs) have beneficial effects on the system. present study examined association between ICVHMs and of hypertension-related CVD in hypertensive patients across different BP ranges. Methods Analyses included 31,427 adults from National Health Nutrition Examination Survey 2005–2018. target was <130/80 mmHg were defined based 2022 American Heart...

10.1093/ajh/hpaf036 article EN American Journal of Hypertension 2025-03-20

Studies have shown that in hypertensive patients, chronic kidney disease (CKD) is associated with a poor prognosis. Inflammation highly important factor the progression of CKD. Detecting systemic inflammation and intervening promptly patients hypertension may help reduce risk The inflammatory response index (SIRI) tool used to measure response, but its relationship CKD remains uncertain.

10.1080/0886022x.2024.2396459 article EN cc-by Renal Failure 2024-09-23

The association between triglyceride-glucose (TyG) index and poor prognosis remains controversial. Whether renal function status affects the ability of TyG to predict has not yet been elucidated merits further studies.This retrospective cohort study included 22,031 participants from communities in U.S. By juxtaposing categories with estimated glomerular filtration rate (eGFR, either < 60 mL/min/1.73m2 or ≥ mL/min/1.73m2), were categorized into four distinct groups: (1) TyG_L/eGFR_H; (2)...

10.1186/s12944-023-01958-1 article EN cc-by Lipids in Health and Disease 2023-11-11

The potential value of N-terminal pro-brain natriuretic peptide (NT-proBNP) for contrast-induced acute kidney injury (CI-AKI) in patients with heart failure and mid-range ejection fraction (HFmrEF) is unclear. We investigated whether NT-proBNP associated CI-AKI long-term mortality following elective cardiac catheterization HFmrEF. A total 174 consecutive HFmrEF undergoing coronary angiography or intervention were enrolled. primary endpoint was the development CI-AKI, defined as an absolute...

10.1097/md.0000000000006259 article EN cc-by-nc Medicine 2017-03-01

This study investigated the prevalence and mortality associated with moderate or severe mitral regurgitation (MR) among patients undergoing percutaneous coronary intervention (PCI), without heart failure (HF). We analyzed PCI valve surgery from Cardiorenal ImprovemeNt (CIN) (ClinicalTrials.gov NCT04407936). Patients echocardiography to determine MR occurrence lacking follow-up death data were excluded. Primary endpoints 1-year long-term all-cause mortality, a median time of 5 years...

10.3389/fcvm.2022.796447 article EN cc-by Frontiers in Cardiovascular Medicine 2022-03-03
Coming Soon ...